Data Analysis and Physical Function Evaluation Index Development for Early Diagnosis and Monitori… (NCT06669494) | Clinical Trial Compass
By InvitationNot Applicable
Data Analysis and Physical Function Evaluation Index Development for Early Diagnosis and Monitoring of ICU-acquired Weakness
South Korea51 participantsStarted 2024-11-01
Plain-language summary
Data Analysis and Physical Function Evaluation Index Development for Early Diagnosis and Monitoring of ICU-acquired weakness
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients admitted to the ICU who are 19 years of age
* Patients who did consent of the study
Exclusion Criteria:
* Patients with a history of peripheral nerve injury
* Patients with a history of major surgery within the past 12 weeks or those expected to undergo major surgery during the trial period
* Patients with a history of central nervous system disorders (e.g., stroke, spinal cord injury)
* Patients with cognitive impairment that may interfere with the conduct of the study
* Patients with Do Not Resuscitate (DNR) orders, brain lesions, Clinical Frailty Score (CFS) exceeding 4, or those who have undergone cardiopulmonary resuscitation
* Patients confirmed to have metastatic cancer
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1My loved one is in the ICU — could they be affected by ICU-acquired weakness, and is this kind of observational study something worth discussing with their care team given that it's enrolling only by invitation?
2This study is tracking muscle strength using grip tests and ultrasound, nerve conduction studies, and wearable devices like the Fitbit Charge 5 — how physically demanding or burdensome would participating in all these measurements be for someone who is critically ill?
3Since this trial is in a 'not applicable' phase and focused on developing diagnostic tools rather than testing a treatment, what would my loved one actually gain from being involved, and how does that compare to simply receiving standard ICU care?
4The study is measuring things like muscle thickness, nerve conduction, and mobility scales — if these tests reveal signs of muscle weakness early, would that information actually change how my loved one is treated during their ICU stay?
5Are there existing standard-of-care approaches to detecting and managing ICU-acquired weakness that my loved one's team is already using, and how does what this study is trying to develop compare to what's already available?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.